back insurance patient resources covid-19 response request records first visit info common clinical fees billing inquiries pay bill

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Ken Liechty, MD

Pediatric Surgery

Board Certified

Schedule Appointment

Locations

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Children's Hospital Colorado - Colorado Fetal Care Center
13123 E 16th Ave, B735 Aurora, CO 80045

720-777-4463

Provider Expertise

Specialties

  • Surgery ( 2004 , 2014 )
  • Pediatric Surgery ( 2006 )

Conditions & Treatments

  • Pregnancy and Reproduction

    Maternal and Fetal Health, Neonatal Intensive Care, Prenatal Care, Prenatal Testing

  • Surgery

    Fetal

Education & Training

Medical Schools

MD, University of Utah School of Medicine (1994)


Undergraduate Schools

BS, University of Utah (UT) (1989)


Internships

Drexel University College of Medicine/Hahnemann University Hospital Program (1995)


Residency Program

Hospital of the University of Pennsylvania (2002)


Fellowships

Children's Hospital of Philadelphia Program (2004)

Children's Hospital of Philadelphia Program (1999)

Professional Memberships

American Academy of Pediatrics (AAP), Fellow


American College of Surgeons (ACS), Fellow


American Pediatric Surgical Association (APSA), Member


College of Physicians of Philadelphia, Member


International Fetal Medicine and Surgical Society (IFMSS), Member


The Hardy Society, Member


The Society of University Surgeons (SUS), Member


The Wound Healing Society (WHS), Member


Ths Association for Academic Surgery (AAS), Member


Research & Grants

Grants

Interleukin-10 Inhibition of Inflammation in Fetal Tissues (2005)

The Role of Mesenchymal Stem Cells in the Response to Injury: Direct and Indirect Mechanisms of Participation (2005)

Modulation of the Inflammatory and Cellular Response During Post-natal Wound Healing: Bioengineered Regenerative Healing (2007)

R56-Progenitor Cells in Diabetes Impaired Wound Healing (2008)

The Role of Inflammation in Regenerative Fetal Tendon Wound Healing. (2008)

DP2-Extracellular Matrix Structure and Function (2008)

Pro-Angiogenic and Inorganic Regenerative Nano Antioxidant For Wound Healing Application in Diabetic Mice Model (2013)

CXCR4 Agonist High Throughput Screening (2014)

Identifying CXCR4 Receptor Agonists to Improve Diabetic Wound Healing (2016)

Cerium Nanoparticles in diabetic wounds (2017)

Cerium Nanoparticles in acute lung injury (2019)

Modulation of inflammation and oxidative stress in diabetic wound healing (2019)

The role of long non-coding RNA GAS5 in diabetic wounds (2019)


information for referring providers

Referral Contact Phone

720-777-1234

Clinical Interests for Referring Providers

Pediatric and Neonatal Surgery Fetal Diagnosis and Treatment Congenital Anomalies

Research Interest for Referring Providers

Research in my laboratory has been focused primarily in the field of wound healing and regenerative medicine, with an emphasis on elucidating the mechanisms involved in the regenerative response to injury in the fetus, the role of stem cells in tissue repair, and the correction of abnormal healing in the adult. The team has contributed significantly to the understanding of regenerative healing in the skin and tendon, as well as the correction of impaired healing in diabetics. The research team has also pioneered the role of dysregulation of microRNAs in the diabetic wound healing impairment and the mechanisms of stem cell and gene therapy in the correction of this impairment. In addition, this team has published the first reports of mammalian cardiac regeneration following myocardial infarction in fetal sheep. This team is focused on developing novel treatment paradigms using stem cells, small molecules, and gene therapy strategies to promote healing and tissue regeneration in multiple tissues by modulating the inflammatory response, angiogenesis, the composition of the extracellular matrix, and the progenitor cell content. The goal of this regenerative medicine approach is to restore normal tissue architecture and function and to prevent the complications of impaired healing or scar formation following injury.